Equine Healthcare Market - Global Professional Analysis and Forecast to 2026

Oct 26, 2019  |  218 PAGES  |  REPORT CODE: CMM224972
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Equine Healthcare market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.1% during the forecast period.

This report presents the market size and development trends by detailing the Equine Healthcare market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Equine Healthcare market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Equine Healthcare industry and will help you to build a panoramic view of the industrial development.

Equine Healthcare Market, By Type:

  • Supplement Product

  • Therapeutic Product

  • Diagnostic Product

Equine Healthcare Market, By Application:

  • Race Equine

  • Sport Equine

Some of the leading players are as follows:

  • Merck

  • Phirbo Animal Health

  • Zoetis

  • Neogen

  • Virbac

  • Vetoquinol

  • Cargill

  • Dechra Pharmaceuticals

  • Boehringer Ingelheim

  • Ceva Sante Animale

  • Evonik Industries

  • Bayer

  • Eli Lilly and Company

  • Nutreco N.V.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Equine Healthcare Market: Technology Type Analysis

  • 4.1 Equine Healthcare Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Equine Healthcare Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Supplement Product

    • 4.3.2 Therapeutic Product

    • 4.3.3 Diagnostic Product

5 Equine Healthcare Market: Product Analysis

  • 5.1 Equine Healthcare Product Market Share Analysis, 2018 & 2026

  • 5.2 Equine Healthcare Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Equine Healthcare Market: Application Analysis

  • 6.1 Equine Healthcare Application Market Share Analysis, 2018 & 2026

  • 6.2 Equine Healthcare Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Race Equine

    • 6.3.2 Sport Equine

7 Equine Healthcare Market: Regional Analysis

  • 7.1 Equine Healthcare Regional Market Share Analysis, 2018 & 2026

  • 7.2 Equine Healthcare Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Merck

    • 9.1.1 Merck Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Phirbo Animal Health

    • 9.2.1 Phirbo Animal Health Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Zoetis

    • 9.3.1 Zoetis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Neogen

    • 9.4.1 Neogen Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Virbac

    • 9.5.1 Virbac Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Vetoquinol

    • 9.6.1 Vetoquinol Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Cargill

    • 9.7.1 Cargill Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Dechra Pharmaceuticals

    • 9.8.1 Dechra Pharmaceuticals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Boehringer Ingelheim

    • 9.9.1 Boehringer Ingelheim Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Ceva Sante Animale

    • 9.10.1 Ceva Sante Animale Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Evonik Industries

    • 9.11.1 Evonik Industries Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Bayer

    • 9.12.1 Bayer Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Eli Lilly and Company

    • 9.13.1 Eli Lilly and Company Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Nutreco N.V.

    • 9.14.1 Nutreco N.V. Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

 

The List of Tables and Figures (Totals 96 Figures and 156 Tables)

  • Figure Supplement Product Equine Healthcare market, 2015 - 2026 (USD Million)

  • Figure Therapeutic Product Equine Healthcare market, 2015 - 2026 (USD Million)

  • Figure Diagnostic Product Equine Healthcare market, 2015 - 2026 (USD Million)

  • Figure Race Equine market, 2015 - 2026 (USD Million)

  • Figure Sport Equine market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Equine Healthcare market, by country, 2015 - 2026 (USD Million)

  • Table North America Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table North America Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table North America Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Canada Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Canada Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Europe Equine Healthcare market, by country, 2015 - 2026 (USD Million)

  • Table Europe Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Europe Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Europe Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Germany Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Germany Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table France Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table France Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Italy Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Italy Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Spain Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Spain Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Healthcare market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table China Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table China Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Japan Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Japan Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table India Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table India Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Equine Healthcare market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table MEA Equine Healthcare market, by country, 2015 - 2026 (USD Million)

  • Table MEA Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table MEA Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table MEA Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Equine Healthcare market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Equine Healthcare market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Equine Healthcare market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Phirbo Animal Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zoetis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Neogen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Virbac Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vetoquinol Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cargill Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dechra Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ceva Sante Animale Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Evonik Industries Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nutreco N.V. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top